Sensitivity of frozen section analysis in patients with ovarian adult granulosa cell tumor, a multi-center study.

Adult granulosa cell tumor Frozen section Ovarian neoplasms Sensitivity

Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
30 Aug 2024
Historique:
received: 28 05 2024
accepted: 18 08 2024
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 30 8 2024
Statut: aheadofprint

Résumé

We aimed to demonstrate the sensitivity of frozen section for patients with adult granulosa cell tumor (AGCT) and analyze the clinico-pathological factors that may be associated with sensitivity. This is a multicenter study including data of 10 Gynecological Oncology Departments. Frozen-section results of patients who had ovarian AGCT at the final pathology report were retrospectively analyzed. The relation between clinico-pathological characteristics such as age, tumor size, Ca-125 level, presence of ascites, omental metastasis, menopausal status and peritoneal cytology, and the sensitivity of frozen section in patients with AGCT were evaluated. The sensitivity of frozen section diagnosis was determined by comparing the frozen section result with the final pathological diagnosis. Frozen section results of 274 patients with AGCT were obtained. The median age of the patients was 52 years (range, 17-82 years). Totally, 144 (52.7%, n = 273) patients were postmenopausal. The median tumour size was 90 mm (range, 9-700 mm). The median preoperative Ca-125 level was 23 IU/mL (range, 2-995 IU/mL). The sensitivity of frozen section for detecting AGCT was 76.3%. Any association between the sensitivity of frozen section and menopausal status, presence of ascites, positive cytology, omental metastasis, tumor size, Ca-125 level, age could not be shown. It is important to know the diagnosis of AGCT intraoperatively, and we demonstrated the sensitivity of frozen-section for these tumors as 76.3%.

Identifiants

pubmed: 39214901
doi: 10.1007/s00404-024-07710-z
pii: 10.1007/s00404-024-07710-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Pectasides D, Pectasides E, Psyrri A (2008) Granulosa cell tumor of the ovary. Cancer Treat Rev 34(1):1–12. https://doi.org/10.1016/j.ctrv.2007.08.007
doi: 10.1016/j.ctrv.2007.08.007 pubmed: 17945423
Wang J, Li J, Chen R, Lu X (2018) Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: a world wide database analysis. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2018.03.027
doi: 10.1016/j.ejso.2018.03.027 pubmed: 30786961
Inzani F, Santoro A, Travaglino A, D’Alessandris N, Raffone A, Straccia P, Angelico G, Arciuolo D, Scaglione G, Valente M, Tralongo P, Gallotta V, Zannoni GF (2022) Prognostic predictors in recurrent adult granulosa cell tumors of the ovary: a systematic review and meta-analysis. Arch Gynecol Obstet 306(2):315–321
doi: 10.1007/s00404-021-06305-2 pubmed: 34799743
Ray-Coquard I, Morice P, Lorusso D et al (2018) Non-epithelial ovarian cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(Suppl 4):iv1–iv18. https://doi.org/10.1093/annonc/mdy001
doi: 10.1093/annonc/mdy001 pubmed: 29697741
Mangili G, Ottolina J, Gadducci A et al (2013) Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. Br J Cancer 109(1):29–34. https://doi.org/10.1038/bjc.2013.241
doi: 10.1038/bjc.2013.241 pubmed: 23756859 pmcid: 3708585
Colombo N, Parma G, Zanagnolo V et al (2007) Management of ovarian stromal cell tumors. J Clin Oncol 25:2944–2951. https://doi.org/10.1200/JCO.2007.11.1005
doi: 10.1200/JCO.2007.11.1005 pubmed: 17617526
Wang D, Cao D, Jia C et al (2018) Analysis of oncologic and reproductive outcomes after fertility-sparing surgery in apparent stage I adult granulosa cell tumors. Gynecol Oncol 151(2):275–281. https://doi.org/10.1016/j.ygyno.2018.09.004
doi: 10.1016/j.ygyno.2018.09.004 pubmed: 30219238
Akbarzadeh-Jahromi M, Aslani FS, Raeisi H et al (2022) Comparison of frozen and permanent section diagnosis in ovarian neoplasms: analysis of factors affecting accuracy. Int J Gynecol Pathol 41(4):327–336. https://doi.org/10.3802/jgo.2019.30.e95
doi: 10.3802/jgo.2019.30.e95 pubmed: 34456277
Park JY, Jin KL, Kim DY et al (2012) Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol 125:80–86. https://doi.org/10.1016/j.ygyno.2011.12.442
doi: 10.1016/j.ygyno.2011.12.442 pubmed: 22210469
Amsterdam A, Selvaraj N (1997) Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr Rev 18:435–461. https://doi.org/10.1210/edrv.18.4.0306
doi: 10.1210/edrv.18.4.0306 pubmed: 9267759
Plett H, Ricciardi E, Vacaru V et al (2023) Adult granulosa cell tumors: analysis of outcomes and risk factors for recurrence. Int J Gynecol Cancer. https://doi.org/10.1136/ijgc-2022-003854
doi: 10.1136/ijgc-2022-003854 pubmed: 36759002
Wang D, Xiang Y, Wu M et al (2018) Clinicopathological characteristics and prognosis of adult ovarian granulosa cell tumor: a single-institution experience in China. Onco Targets and Therapy 11:1315–1322. https://doi.org/10.2147/OTT.S155473
doi: 10.2147/OTT.S155473
Nasioudis D, Kanninen TT, Holcomb K et al (2017) Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors. Gynecol Oncol 145(2):243–247. https://doi.org/10.1016/j.ygyno.2017.03.005
doi: 10.1016/j.ygyno.2017.03.005 pubmed: 28292524
Thrall MM, Paley P, Pizer E et al (2011) Patterns of spread and recurrence of sex cord-stromal tumors of the ovary. Gynecol Oncol 122:242–245. https://doi.org/10.1016/j.ygyno.2011.03.020
doi: 10.1016/j.ygyno.2011.03.020 pubmed: 21481441 pmcid: 3138896
Ureyen I, Turan T, Cirik DA et al (2014) Frozen section in borderline ovarian tumors: is it reliable? Eur J Obstet Gynecol Reprod Biol 181:115–118. https://doi.org/10.1016/j.ejogrb.2014.07.039
doi: 10.1016/j.ejogrb.2014.07.039 pubmed: 25145763
Basaran D, Salman MC, Calis P et al (2014) Diagnostic accuracy of intraoperative consultation (frozen section) in borderline ovarian tumours and factors associated with misdiagnosis. J Obstet Gynaecol 34(5):429–434. https://doi.org/10.3109/01443615.2014.9020
doi: 10.3109/01443615.2014.9020 pubmed: 24734941
Singh N, Gilks CB, Huntsman DG, Smith JH, Coutts M, Ganesan R, McCluggage WG (2014) Adult granulosa cell tumour-like areas occurring in ovarian epithelial neoplasms: report of a case series with investigation of FOXL2 mutation status. Histopathology 64(5):626–632
doi: 10.1111/his.12314 pubmed: 24138090

Auteurs

Isin Ureyen (I)

Department of Gynecological Oncology, Antalya Training and Research Hospital, Health Science University, Muratpasa, 07025, Antalya, Turkey.

Tayfun Toptas (T)

Department of Gynecological Oncology, Antalya Training and Research Hospital, Health Science University, Muratpasa, 07025, Antalya, Turkey.

Alp Tokalıoğlu (A)

Department of Gynecological Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Mustafa Sahin (M)

Department of Gynecological Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Okan Oktar (O)

Department of Gynecological Oncology, Etlik Zubeyde Hanim, Women's Health and Research Hospital, Health Science University, Ankara, Turkey.

Merve Kole (M)

Department of Gynecological Oncology, Antalya Training and Research Hospital, Health Science University, Muratpasa, 07025, Antalya, Turkey. merweckr@hotmail.com.

Aysun Alcı (A)

Department of Gynecological Oncology, Antalya Training and Research Hospital, Health Science University, Muratpasa, 07025, Antalya, Turkey.

Cagatayhan Ozturk (C)

Department of Gynecology and Obstetrics, Ankara University Medical School, Ankara, Turkey.

Fatma Ozmen (F)

Department of Gynecological Oncology, Adana City Hospital, Health Science University, Adana, Turkey.

Selin Esen Akturk (SE)

Department of Medical Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Ozgur Erdogan (O)

Department of Gynecological Oncology, Tepecik Training and Research Hospital, Health Science University, Izmir, Turkey.

Burak Ersak (B)

Department of Gynecological Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Fatih Kilic (F)

Department of Gynecological Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Sevda Bas (S)

Department of Gynecological Oncology, Adana City Hospital, Health Science University, Adana, Turkey.

Caner Cakir (C)

Department of Gynecological Oncology, Etlik Zubeyde Hanim, Women's Health and Research Hospital, Health Science University, Ankara, Turkey.

Ozgur Kocak (O)

Department of Gynecology and Obstetrics, Corum Hitit University Medical School, Corum, Turkey.

Çiğdem Kilic (Ç)

Department of Gynecology and Obstetrics, Corum Hitit University Medical School, Corum, Turkey.

Gokhan Ucar (G)

Department of Medical Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Vakkas Korkmaz (V)

Department of Gynecological Oncology, Etlik Zubeyde Hanim, Women's Health and Research Hospital, Health Science University, Ankara, Turkey.

Mehmet Ali Narin (MA)

Department of Gynecological Oncology, Adana City Hospital, Health Science University, Adana, Turkey.

Dogan Uncu (D)

Department of Medical Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Muzaffer Sanci (M)

Department of Gynecological Oncology, Tepecik Training and Research Hospital, Health Science University, Izmir, Turkey.

Gunsu Kimyon Comert (G)

Department of Gynecological Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Bulent Ozdal (B)

Department of Gynecological Oncology, Zekai Tahir Burak, Women's Health and Research Hospital, Ankara, Turkey.

Ozlem Tekin Moralıoglu (O)

Department of Gynecological Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Yaprak Engin Ustun (Y)

Department of Gynecological Oncology, Etlik Zubeyde Hanim, Women's Health and Research Hospital, Health Science University, Ankara, Turkey.

Nurettin Boran (N)

Department of Gynecological Oncology, Etlik Zubeyde Hanim, Women's Health and Research Hospital, Health Science University, Ankara, Turkey.

Salih Taskin (S)

Department of Gynecology and Obstetrics, Ankara University Medical School, Ankara, Turkey.

Tolga Tasci (T)

Department of Gynecological Oncology, Bahcesehir University Medical School, Istanbul, Turkey.

Firat Ortac (F)

Department of Gynecology and Obstetrics, Ankara University Medical School, Ankara, Turkey.

Taner Turan (T)

Department of Gynecological Oncology, Ankara Bilkent City Hospital, Health Science University, Ankara, Turkey.

Classifications MeSH